Teleflex Incorporated vs Eli Lilly & Co.
TFX vs LLY — side-by-side comparison from reported financials. TFX leads 3, LLY leads 9 of 12 comparable metrics.
Teleflex Incorporated
TFX · Healthcare
$125.12+0.75%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | TFX | LLY |
|---|---|---|
| Price | $125.12 | $1 177.20 |
| Market cap | $5.30B | $1.05T |
| Revenue (TTM) | $6.05B | $79.7B |
| Revenue growth | -10.6% | +31.7% |
| Net margin | -16.7% | 33.5% |
| Free cash flow | $229M | $18.2B |
| Net cash (debt) | ($2.61B) | ($35.2B) |
| 1-year price return | +0.3% | +37.6% |
| P/E | 28.7 | 41.6 |
| P/E vs own history (cheap-side %) | 64% | 88% |
| Dividend yield | 1.13% | 0.52% |
| Return on equity | -32% | 93% |
| Altman Z-score | 1.93 | 7.10 |
| CV checks passed | 8 of 11 | 11 of 11 |
| Employees | 15,500 | 50,000 |
Full résumé-style profiles: TFX CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.